? This application seeks support for a Hydropac watering system for rodents and for a Gammacell 40 irradiator. Both pieces of equipment will be installed in the Research Support Building, a five-story animal facility that will open later this year. The Hydropac system will allow provision of filtered, treated water in plastic pouches to animals in individual cages. The system will provide bacteria-free water, reduce animal morbidity and mortality due to water system failures, significantly reduce costs especially those associated with labor, and ensure availability of high-quality water in emergency situations. Because pouches will be distributed to the other facilities on campus where rodents are housed, over 120 federally-funded investigators (representing over $260 million dollars in research funding) will benefit from this system. The Gammacell 40 irradiator will provide a dedicated, animal irradiator maintained within an animal facility. The availability of a biosafety cabinet adjacent to the unit will allow animals to be transferred between filtered cages and filtered exposure chambers without exposing them to pathogens. Personnel exposure to animal allergens or infectious agents will also be minimized. In summary, this proposal contributes to our mission of providing and maintaining consistently high quality, healthy animals for UAB research, testing, and teaching program, assuring care of animals consistent with the standards of the Guide for the Care and Use of Laboratory Animals, providing a safe and healthy workplace for personnel, and containing program costs. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20)
Project #
1G20RR022807-01
Application #
7082597
Study Section
Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities (STRB)
Program Officer
Mccullough, Willie
Project Start
2006-09-01
Project End
2009-02-28
Budget Start
2006-09-01
Budget End
2009-02-28
Support Year
1
Fiscal Year
2006
Total Cost
$646,750
Indirect Cost
Name
University of Alabama Birmingham
Department
Genetics
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Zhao, Qing; Harbour, Stacey N; Kolde, Raivo et al. (2017) Selective Induction of Homeostatic Th17 Cells in the Murine Intestine by Cholera Toxin Interacting with the Microbiota. J Immunol 199:312-322
Huo, Yongliang; Lockhart, Jonathan R; Liu, Shanrun et al. (2017) Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with ?-thalassemia major. Blood Adv 1:2421-2432
Botta, Davide; Fuller, Michael J; Marquez-Lago, Tatiana T et al. (2017) Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection. Nat Immunol 18:1249-1260
Mier-Aguilar, Carlos A; Cashman, Kevin S; Raman, Chander et al. (2016) CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival. PLoS One 11:e0168155
Yang, Zhenhua; Shah, Kushani; Khodadadi-Jamayran, Alireza et al. (2016) Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells. J Exp Med 213:2349-2364
Robert, Stephanie M; Ogunrinu-Babarinde, Toyin; Holt, Kenneth T et al. (2014) Role of glutamate transporters in redox homeostasis of the brain. Neurochem Int 73:181-91
McGuire, Donald J; Rowse, Amber L; Li, Hao et al. (2014) CD5 enhances Th17-cell differentiation by regulating IFN-? response and ROR?t localization. Eur J Immunol 44:1137-42
Chewning, Joseph H; Zhang, Weiwei; Randolph, David A et al. (2013) Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFN?-dependent aplasia. Biol Blood Marrow Transplant 19:876-87
Harms, Ashley S; Cao, Shuwen; Rowse, Amber L et al. (2013) MHCII is required for ?-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33:9592-600
Sweeny, Larissa; Hartman, Yolanda E; Zinn, Kurt R et al. (2013) A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncol 49:991-7

Showing the most recent 10 out of 13 publications